Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed

Ceci, A; Conte, R; Didio, A; Landi, A; Ruggieri, L; Giannuzzi, V; Bonifazi, F

Ceci, A (通讯作者)，Fdn Ric Farmacolog Gianni Benzi Onlus, Res Dept, Bari, Italy.

FRONTIERS IN MEDICINE, 2023; 10 ():

Abstract

IntroductionSeveral new active substances (ASs) targeting neuroblastoma (NBL) are under study. We aim to describe the developmental and regulatory sta......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索